Literature DB >> 19920758

Spinal cord protection and thoracic aortic surgery.

Ashish C Sinha1, Albert T Cheung.   

Abstract

PURPOSE OF REVIEW: Spinal cord ischemia remains an important complication of open surgical and endovascular stent graft repair of thoracic and thoracoabdominal aortic aneurysm despite advances in operative technique. Identification of risk factors and interventions to prevent and treat spinal cord ischemia has the potential to prevent spinal cord infarction and the morbidity and mortality associated with paraplegia. RECENT
FINDINGS: Risk factors for spinal cord ischemia are aneurysm extent, open surgical repair, prior distal aortic operations, and perioperative hypotension. Augmenting spinal cord perfusion by increasing arterial pressure, lumbar cerebrospinal fluid drainage, and reattachment of segmental arteries are effective for the treatment of spinal cord ischemia. Early detection of spinal cord ischemia by intraoperative neurophysiologic monitoring and postoperative neurological examination is important to enable immediate treatment to prevent permanent paraplegia.
SUMMARY: Permanent paraplegia after thoracic and thoracoabdominal aortic aneurysm repair can be prevented in many high-risk patients by early detection and immediate treatment of spinal cord ischemia before it evolves to infarction. The mortality and morbidity associated with permanent paraplegia justifies the risks and uncertainties associated with established therapeutic interventions.

Entities:  

Mesh:

Year:  2010        PMID: 19920758     DOI: 10.1097/ACO.0b013e3283348975

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  13 in total

Review 1.  [Remission of incomplete paraplegia after thoracic stent graft implantation. Case report and review of the literature].

Authors:  A Jacobs; T Jahnke; H Baum; H Brammer; H-C Hansen
Journal:  Nervenarzt       Date:  2012-04       Impact factor: 1.214

Review 2.  Perioperative management of thoracic and thoracoabdominal aneurysms.

Authors:  S Agarwal; J Kendall; C Quarterman
Journal:  BJA Educ       Date:  2019-02-14

3.  Spinal cord protection and related complications in endovascular management of B dissection: LSA revascularization and CSF drainage.

Authors:  Vincent Riambau; Laura Capoccia; Gaspar Mestres; Purificiacion Matute
Journal:  Ann Cardiothorac Surg       Date:  2014-05

Review 4.  [Management of anesthesia in endovascular interventions].

Authors:  T Rössel; R Paul; T Richter; S Ludwig; T Hofmockel; A R Heller; T Koch
Journal:  Anaesthesist       Date:  2016-12       Impact factor: 1.041

5.  Post-dural puncture headaches following spinal drain placement during thoracoabdominal aortic aneurysm repair: incidence, associated risk factors, and treatment.

Authors:  Sean P Riley; Melanie J Donnelly; Didi Khatib; Christopher Warren; Kristopher M Schroeder
Journal:  J Anesth       Date:  2015-03-05       Impact factor: 2.078

Review 6.  [Intraoperative electrophysiological monitoring with evoked potentials].

Authors:  R Nitzschke; N Hansen-Algenstaedt; J Regelsberger; A E Goetz; M S Goepfert
Journal:  Anaesthesist       Date:  2012-04       Impact factor: 1.041

7.  Analysis of Spinal Cord Infarction Associated with Aortic Stent Graft Placement Using Nationwide Inpatient Sample (2002-2011).

Authors:  Adnan I Qureshi; Morad Chughtai; Ahmed A Malik
Journal:  J Vasc Interv Neurol       Date:  2016-01

Review 8.  Severe spinal cord ischemic injury secondary to device embolization after transcatheter closure of a patent arterial duct.

Authors:  Liang Tang; Shenghua Zhou; Xiangqian Shen
Journal:  Tex Heart Inst J       Date:  2014-02

Review 9.  Review of the History of Non-traumatic Spinal Cord Dysfunction.

Authors:  Peter Wayne New; Fin Biering-Sørensen
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017

10.  Hypoxic preconditioning increases the protective effect of bone marrow mesenchymal stem cells on spinal cord ischemia/reperfusion injury.

Authors:  Zhilin Wang; Bo Fang; Zhibin Tan; Dong Zhang; Hong Ma
Journal:  Mol Med Rep       Date:  2016-01-11       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.